cd /news/artificial-intelligence/investors-bet-on-ai-drug-discovery-d… · home › topics › artificial-intelligence › article
[ARTICLE · art-66483] src=machinebrief.com ↗ pub= topic=artificial-intelligence verified=true sentiment=· neutral

Investors bet on AI drug discovery despite approval gap

Dimension Capital, a US specialist venture firm, has raised an $800mn fund to back AI-designed medicines, signaling continued investor confidence in AI drug discovery despite no AI-discovered drugs having received regulatory approval yet.

read1 min views40 publishedJul 21, 2026

Source:

Financial Times TechnologyUS specialist venture firm Dimension Capital raises $800mn fund to back AI-designed medicines

Get AI news in your inbox

Daily digest of what matters in AI.

Get AI news in your inbox

Daily digest of what matters in AI.

source & further reading
machinebrief.com — original article Agentic AI Is Here: Is Your Data Ready? AI Isn’t Replacing Stock Brokers– It’s Making Them Better An Interview with OpenAI President Greg Brockman About Astra and Alignment
── more in #artificial-intelligence 4 stories · sorted by recency
── more on @dimension capital 3 stories trending now
sponsored brought to you by zahid.host 4,200+ EU-deployed projects
reading about agents? ship yours in a single git push.

Run your AI side-project on zahid.host

EU-based hosting, git-push deploys, automatic HTTPS, no cold starts. Free tier with a custom domain — perfect for shipping the agent you just read about.

$git push zahid main
→ Live at https://your-agent.zahid.host ✓
Get free account → Pricing
from €0/mo · no card required
LIVE [news/investors-bet-on-ai-…] indexed:0 read:1min 2026-07-21 · —